Global Liver Diseases Therapeutics Drugs Market 2019 - by Manufacturers, Regions, Type, Application, Sales, Revenue, and Forecast to 2025

  • In 2017, the global Liver Diseases Therapeutics Drugs market size was  million US$ and it is expected to reach  million US$ by the end of 2025, with a CAGR of  during 2018-2025.
    
    This report focuses on the global Liver Diseases Therapeutics Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Liver Diseases Therapeutics Drugs development in United States, Europe and China.
    
    The key players covered in this study
        F. Hoffmann-La Roche
        Gilead Sciences
        GlaxoSmithKline
        Johnson & Johnson
        Merck
        Achillion Pharmaceuticals
        AbbVie
        Angion Biomedica
        Bayer
        LG Life Sciences
        Phenex Pharmaceuticals
        ProMetic Life Sciences
        Raptor Pharmaceuticals
        Shenzhen Kangtai Biological Products
        Verva Pharmaceuticals
    
    Market segment by Type, the product can be split into
        Oral
        Injection
    
    Market segment by Application, split into
        Hospitals
        Clinics
        Other
    
    Market segment by Regions/Countries, this report covers
        United States
        Europe
        China
        Japan
        Southeast Asia
        India
        Central & South America
    
    The study objectives of this report are:
        To analyze global Liver Diseases Therapeutics Drugs status, future forecast, growth opportunity, key market and key players.
        To present the Liver Diseases Therapeutics Drugs development in United States, Europe and China.
        To strategically profile the key players and comprehensively analyze their development plan and strategies.
        To define, describe and forecast the market by product type, market and key regions.
    
    In this study, the years considered to estimate the market size of Liver Diseases Therapeutics Drugs are as follows:
        History Year: 2013-2017
        Base Year: 2017
        Estimated Year: 2018
        Forecast Year 2018 to 2025
    For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
  • 
    1 Report Overview
        1.1 Study Scope
        1.2 Key Market Segments
        1.3 Players Covered
        1.4 Market Analysis by Type
            1.4.1 Global Liver Diseases Therapeutics Drugs Market Size Growth Rate by Type (2013-2025)
            1.4.2 Oral
            1.4.3 Injection
        1.5 Market by Application
            1.5.1 Global Liver Diseases Therapeutics Drugs Market Share by Application (2013-2025)
            1.5.2 Hospitals
            1.5.3 Clinics
            1.5.4 Other
        1.6 Study Objectives
        1.7 Years Considered
    
    2 Global Growth Trends
        2.1 Liver Diseases Therapeutics Drugs Market Size
        2.2 Liver Diseases Therapeutics Drugs Growth Trends by Regions
            2.2.1 Liver Diseases Therapeutics Drugs Market Size by Regions (2013-2025)
            2.2.2 Liver Diseases Therapeutics Drugs Market Share by Regions (2013-2018)
        2.3 Industry Trends
            2.3.1 Market Top Trends
            2.3.2 Market Drivers
            2.3.3 Market Opportunities
    
    3 Market Share by Key Players
        3.1 Liver Diseases Therapeutics Drugs Market Size by Manufacturers
            3.1.1 Global Liver Diseases Therapeutics Drugs Revenue by Manufacturers (2013-2018)
            3.1.2 Global Liver Diseases Therapeutics Drugs Revenue Market Share by Manufacturers (2013-2018)
            3.1.3 Global Liver Diseases Therapeutics Drugs Market Concentration Ratio (CR5 and HHI)
        3.2 Liver Diseases Therapeutics Drugs Key Players Head office and Area Served
        3.3 Key Players Liver Diseases Therapeutics Drugs Product/Solution/Service
        3.4 Date of Enter into Liver Diseases Therapeutics Drugs Market
        3.5 Mergers & Acquisitions, Expansion Plans
    
    4 Breakdown Data by Type and Application
        4.1 Global Liver Diseases Therapeutics Drugs Market Size by Type (2013-2018)
        4.2 Global Liver Diseases Therapeutics Drugs Market Size by Application (2013-2018)
    
    5 United States
        5.1 United States Liver Diseases Therapeutics Drugs Market Size (2013-2018)
        5.2 Liver Diseases Therapeutics Drugs Key Players in United States
        5.3 United States Liver Diseases Therapeutics Drugs Market Size by Type
        5.4 United States Liver Diseases Therapeutics Drugs Market Size by Application
    
    6 Europe
        6.1 Europe Liver Diseases Therapeutics Drugs Market Size (2013-2018)
        6.2 Liver Diseases Therapeutics Drugs Key Players in Europe
        6.3 Europe Liver Diseases Therapeutics Drugs Market Size by Type
        6.4 Europe Liver Diseases Therapeutics Drugs Market Size by Application
    
    7 China
        7.1 China Liver Diseases Therapeutics Drugs Market Size (2013-2018)
        7.2 Liver Diseases Therapeutics Drugs Key Players in China
        7.3 China Liver Diseases Therapeutics Drugs Market Size by Type
        7.4 China Liver Diseases Therapeutics Drugs Market Size by Application
    
    8 Japan
        8.1 Japan Liver Diseases Therapeutics Drugs Market Size (2013-2018)
        8.2 Liver Diseases Therapeutics Drugs Key Players in Japan
        8.3 Japan Liver Diseases Therapeutics Drugs Market Size by Type
        8.4 Japan Liver Diseases Therapeutics Drugs Market Size by Application
    
    9 Southeast Asia
        9.1 Southeast Asia Liver Diseases Therapeutics Drugs Market Size (2013-2018)
        9.2 Liver Diseases Therapeutics Drugs Key Players in Southeast Asia
        9.3 Southeast Asia Liver Diseases Therapeutics Drugs Market Size by Type
        9.4 Southeast Asia Liver Diseases Therapeutics Drugs Market Size by Application
    
    10 India
        10.1 India Liver Diseases Therapeutics Drugs Market Size (2013-2018)
        10.2 Liver Diseases Therapeutics Drugs Key Players in India
        10.3 India Liver Diseases Therapeutics Drugs Market Size by Type
        10.4 India Liver Diseases Therapeutics Drugs Market Size by Application
    
    11 Central & South America
        11.1 Central & South America Liver Diseases Therapeutics Drugs Market Size (2013-2018)
        11.2 Liver Diseases Therapeutics Drugs Key Players in Central & South America
        11.3 Central & South America Liver Diseases Therapeutics Drugs Market Size by Type
        11.4 Central & South America Liver Diseases Therapeutics Drugs Market Size by Application
    
    12 International Players Profiles
        12.1 F. Hoffmann-La Roche
            12.1.1 F. Hoffmann-La Roche Company Details
            12.1.2 Company Description and Business Overview
            12.1.3 Liver Diseases Therapeutics Drugs Introduction
            12.1.4 F. Hoffmann-La Roche Revenue in Liver Diseases Therapeutics Drugs Business (2013-2018)
            12.1.5 F. Hoffmann-La Roche Recent Development
        12.2 Gilead Sciences
            12.2.1 Gilead Sciences Company Details
            12.2.2 Company Description and Business Overview
            12.2.3 Liver Diseases Therapeutics Drugs Introduction
            12.2.4 Gilead Sciences Revenue in Liver Diseases Therapeutics Drugs Business (2013-2018)
            12.2.5 Gilead Sciences Recent Development
        12.3 GlaxoSmithKline
            12.3.1 GlaxoSmithKline Company Details
            12.3.2 Company Description and Business Overview
            12.3.3 Liver Diseases Therapeutics Drugs Introduction
            12.3.4 GlaxoSmithKline Revenue in Liver Diseases Therapeutics Drugs Business (2013-2018)
            12.3.5 GlaxoSmithKline Recent Development
        12.4 Johnson & Johnson
            12.4.1 Johnson & Johnson Company Details
            12.4.2 Company Description and Business Overview
            12.4.3 Liver Diseases Therapeutics Drugs Introduction
            12.4.4 Johnson & Johnson Revenue in Liver Diseases Therapeutics Drugs Business (2013-2018)
            12.4.5 Johnson & Johnson Recent Development
        12.5 Merck
            12.5.1 Merck Company Details
            12.5.2 Company Description and Business Overview
            12.5.3 Liver Diseases Therapeutics Drugs Introduction
            12.5.4 Merck Revenue in Liver Diseases Therapeutics Drugs Business (2013-2018)
            12.5.5 Merck Recent Development
        12.6 Achillion Pharmaceuticals
            12.6.1 Achillion Pharmaceuticals Company Details
            12.6.2 Company Description and Business Overview
            12.6.3 Liver Diseases Therapeutics Drugs Introduction
            12.6.4 Achillion Pharmaceuticals Revenue in Liver Diseases Therapeutics Drugs Business (2013-2018)
            12.6.5 Achillion Pharmaceuticals Recent Development
        12.7 AbbVie
            12.7.1 AbbVie Company Details
            12.7.2 Company Description and Business Overview
            12.7.3 Liver Diseases Therapeutics Drugs Introduction
            12.7.4 AbbVie Revenue in Liver Diseases Therapeutics Drugs Business (2013-2018)
            12.7.5 AbbVie Recent Development
        12.8 Angion Biomedica
            12.8.1 Angion Biomedica Company Details
            12.8.2 Company Description and Business Overview
            12.8.3 Liver Diseases Therapeutics Drugs Introduction
            12.8.4 Angion Biomedica Revenue in Liver Diseases Therapeutics Drugs Business (2013-2018)
            12.8.5 Angion Biomedica Recent Development
        12.9 Bayer
            12.9.1 Bayer Company Details
            12.9.2 Company Description and Business Overview
            12.9.3 Liver Diseases Therapeutics Drugs Introduction
            12.9.4 Bayer Revenue in Liver Diseases Therapeutics Drugs Business (2013-2018)
            12.9.5 Bayer Recent Development
        12.10 LG Life Sciences
            12.10.1 LG Life Sciences Company Details
            12.10.2 Company Description and Business Overview
            12.10.3 Liver Diseases Therapeutics Drugs Introduction
            12.10.4 LG Life Sciences Revenue in Liver Diseases Therapeutics Drugs Business (2013-2018)
            12.10.5 LG Life Sciences Recent Development
        12.11 Phenex Pharmaceuticals
        12.12 ProMetic Life Sciences
        12.13 Raptor Pharmaceuticals
        12.14 Shenzhen Kangtai Biological Products
        12.15 Verva Pharmaceuticals
    
    13 Market Forecast 2018-2025
        13.1 Market Size Forecast by Regions
        13.2 United States
        13.3 Europe
        13.4 China
        13.5 Japan
        13.6 Southeast Asia
        13.7 India
        13.8 Central & South America
        13.9 Market Size Forecast by Product (2018-2025)
        13.10 Market Size Forecast by Application (2018-2025)
    
    14 Analyst's Viewpoints/Conclusions
    
    15 Appendix
        15.1 Research Methodology
            15.1.1 Methodology/Research Approach
                15.1.1.1 Research Programs/Design
                15.1.1.2 Market Size Estimation
                12.1.1.3 Market Breakdown and Data Triangulation
            15.1.2 Data Source
                15.1.2.1 Secondary Sources
                15.1.2.2 Primary Sources
        15.2 Disclaimer
        15.3 Author Details



    List of Tables and Figures
    
        Table Liver Diseases Therapeutics Drugs Key Market Segments
        Table Key Players Liver Diseases Therapeutics Drugs Covered
        Table Global Liver Diseases Therapeutics Drugs Market Size Growth Rate by Type 2013-2025 (Million US$)
        Figure Global Liver Diseases Therapeutics Drugs Market Size Market Share by Type 2013-2025
        Figure Oral Figures
        Table Key Players of Oral
        Figure Injection Figures
        Table Key Players of Injection
        Table Global Liver Diseases Therapeutics Drugs Market Size Growth by Application 2013-2025 (Million US$)
        Figure Hospitals Case Studies
        Figure Clinics Case Studies
        Figure Other Case Studies
        Figure Liver Diseases Therapeutics Drugs Report Years Considered
        Table Global Liver Diseases Therapeutics Drugs Market Size 2013-2025 (Million US$)
        Figure Global Liver Diseases Therapeutics Drugs Market Size and Growth Rate 2013-2025 (Million US$)
        Table Global Liver Diseases Therapeutics Drugs Market Size by Regions 2013-2025 (Million US$)
        Table Global Liver Diseases Therapeutics Drugs Market Size by Regions 2013-2018 (Million US$)
        Table Global Liver Diseases Therapeutics Drugs Market Share by Regions 2013-2018
        Figure Global Liver Diseases Therapeutics Drugs Market Share by Regions 2013-2018
        Figure Global Liver Diseases Therapeutics Drugs Market Share by Regions 2018
        Table Market Top Trends
        Table Global Liver Diseases Therapeutics Drugs Revenue by Manufacturers (2013-2018) (Million US$)
        Table Global Liver Diseases Therapeutics Drugs Market Share by Manufacturers (2013-2018)
        Figure Global Liver Diseases Therapeutics Drugs Market Share by Manufacturers in 2018
        Table Global Liver Diseases Therapeutics Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
        Table Key Players Head office and Area Served
        Table Key Players Liver Diseases Therapeutics Drugs Product/Solution/Service
        Table Date of Enter into Liver Diseases Therapeutics Drugs Market
        Table Mergers & Acquisitions, Expansion Plans
        Table Global Liver Diseases Therapeutics Drugs Market Size by Type (2013-2018) (Million US$)
        Table Global Liver Diseases Therapeutics Drugs Market Size Share by Type (2013-2018)
        Figure Global Liver Diseases Therapeutics Drugs Market Size Market Share by Type (2013-2018)
        Table Global Liver Diseases Therapeutics Drugs Market Size by Application (2013-2018) (Million US$)
        Table Global Liver Diseases Therapeutics Drugs Market Size Share by Application (2013-2018)
        Figure Global Liver Diseases Therapeutics Drugs Market Size Market Share by Application (2013-2018)
        Figure Global Liver Diseases Therapeutics Drugs Revenue Market Share by Application in 2017
        Figure United States Liver Diseases Therapeutics Drugs Market Size 2013-2018 (Million US$)
        Table United States Key Players Liver Diseases Therapeutics Drugs Revenue (2017-2018) (Million US$)
        Table United States Key Players Liver Diseases Therapeutics Drugs Market Share (2017-2018)
        Table United States Liver Diseases Therapeutics Drugs Market Size by Type (2013-2018) (Million US$)
        Table United States Liver Diseases Therapeutics Drugs Market Share by Type (2013-2018)
        Table United States Liver Diseases Therapeutics Drugs Market Size by Application (2013-2018) (Million US$)
        Table United States Liver Diseases Therapeutics Drugs Market Share by Application (2013-2018)
        Figure Europe Liver Diseases Therapeutics Drugs Market Size 2013-2018 (Million US$)
        Table Europe Key Players Liver Diseases Therapeutics Drugs Revenue (2017-2018) (Million US$)
        Table Europe Key Players Liver Diseases Therapeutics Drugs Market Share (2017-2018)
        Table Europe Liver Diseases Therapeutics Drugs Market Size by Type (2013-2018) (Million US$)
        Table Europe Liver Diseases Therapeutics Drugs Market Share by Type (2013-2018)
        Table Europe Liver Diseases Therapeutics Drugs Market Size by Application (2013-2018) (Million US$)
        Table Europe Liver Diseases Therapeutics Drugs Market Share by Application (2013-2018)
        Figure China Liver Diseases Therapeutics Drugs Market Size 2013-2018 (Million US$)
        Table China Key Players Liver Diseases Therapeutics Drugs Revenue (2017-2018) (Million US$)
        Table China Key Players Liver Diseases Therapeutics Drugs Market Share (2017-2018)
        Table China Liver Diseases Therapeutics Drugs Market Size by Type (2013-2018) (Million US$)
        Table China Liver Diseases Therapeutics Drugs Market Share by Type (2013-2018)
        Table China Liver Diseases Therapeutics Drugs Market Size by Application (2013-2018) (Million US$)
        Table China Liver Diseases Therapeutics Drugs Market Share by Application (2013-2018)
        Figure Japan Liver Diseases Therapeutics Drugs Market Size 2013-2018 (Million US$)
        Table Japan Key Players Liver Diseases Therapeutics Drugs Revenue (2017-2018) (Million US$)
        Table Japan Key Players Liver Diseases Therapeutics Drugs Market Share (2017-2018)
        Table Japan Liver Diseases Therapeutics Drugs Market Size by Type (2013-2018) (Million US$)
        Table Japan Liver Diseases Therapeutics Drugs Market Share by Type (2013-2018)
        Table Japan Liver Diseases Therapeutics Drugs Market Size by Application (2013-2018) (Million US$)
        Table Japan Liver Diseases Therapeutics Drugs Market Share by Application (2013-2018)
        Figure Southeast Asia Liver Diseases Therapeutics Drugs Market Size 2013-2018 (Million US$)
        Table Southeast Asia Key Players Liver Diseases Therapeutics Drugs Revenue (2017-2018) (Million US$)
        Table Southeast Asia Key Players Liver Diseases Therapeutics Drugs Market Share (2017-2018)
        Table Southeast Asia Liver Diseases Therapeutics Drugs Market Size by Type (2013-2018) (Million US$)
        Table Southeast Asia Liver Diseases Therapeutics Drugs Market Share by Type (2013-2018)
        Table Southeast Asia Liver Diseases Therapeutics Drugs Market Size by Application (2013-2018) (Million US$)
        Table Southeast Asia Liver Diseases Therapeutics Drugs Market Share by Application (2013-2018)
        Figure India Liver Diseases Therapeutics Drugs Market Size 2013-2018 (Million US$)
        Table India Key Players Liver Diseases Therapeutics Drugs Revenue (2017-2018) (Million US$)
        Table India Key Players Liver Diseases Therapeutics Drugs Market Share (2017-2018)
        Table India Liver Diseases Therapeutics Drugs Market Size by Type (2013-2018) (Million US$)
        Table India Liver Diseases Therapeutics Drugs Market Share by Type (2013-2018)
        Table India Liver Diseases Therapeutics Drugs Market Size by Application (2013-2018) (Million US$)
        Table India Liver Diseases Therapeutics Drugs Market Share by Application (2013-2018)
        Figure Central & South America Liver Diseases Therapeutics Drugs Market Size 2013-2018 (Million US$)
        Table Central & South America Key Players Liver Diseases Therapeutics Drugs Revenue (2017-2018) (Million US$)
        Table Central & South America Key Players Liver Diseases Therapeutics Drugs Market Share (2017-2018)
        Table Central & South America Liver Diseases Therapeutics Drugs Market Size by Type (2013-2018) (Million US$)
        Table Central & South America Liver Diseases Therapeutics Drugs Market Share by Type (2013-2018)
        Table Central & South America Liver Diseases Therapeutics Drugs Market Size by Application (2013-2018) (Million US$)
        Table Central & South America Liver Diseases Therapeutics Drugs Market Share by Application (2013-2018)
        Table F. Hoffmann-La Roche Company Details
        Table F. Hoffmann-La Roche Revenue in Liver Diseases Therapeutics Drugs Business (2013-2018) (Million US$)
        Figure F. Hoffmann-La Roche Revenue Growth Rate in Liver Diseases Therapeutics Drugs Business (2013-2018)
        Table F. Hoffmann-La Roche Recent Development
        Table Gilead Sciences Company Details
        Table Gilead Sciences Revenue in Liver Diseases Therapeutics Drugs Business (2013-2018)(Million US$)
        Figure Gilead Sciences Revenue Growth Rate in Liver Diseases Therapeutics Drugs Business (2013-2018)
        Table Gilead Sciences Recent Development
        Table GlaxoSmithKline Company Details
        Table GlaxoSmithKline Revenue in Liver Diseases Therapeutics Drugs Business (2013-2018)(Million US$)
        Figure GlaxoSmithKline Revenue Growth Rate in Liver Diseases Therapeutics Drugs Business (2013-2018)
        Table GlaxoSmithKline Recent Development
        Table Johnson & Johnson Company Details
        Table Johnson & Johnson Revenue in Liver Diseases Therapeutics Drugs Business (2013-2018)(Million US$)
        Figure Johnson & Johnson Revenue Growth Rate in Liver Diseases Therapeutics Drugs Business (2013-2018)
        Table Johnson & Johnson Recent Development
        Table Merck Company Details
        Table Merck Revenue in Liver Diseases Therapeutics Drugs Business (2013-2018)(Million US$)
        Figure Merck Revenue Growth Rate in Liver Diseases Therapeutics Drugs Business (2013-2018)
        Table Merck Recent Development
        Table Achillion Pharmaceuticals Company Details
        Table Achillion Pharmaceuticals Revenue in Liver Diseases Therapeutics Drugs Business (2013-2018)(Million US$)
        Figure Achillion Pharmaceuticals Revenue Growth Rate in Liver Diseases Therapeutics Drugs Business (2013-2018)
        Table Achillion Pharmaceuticals Recent Development
        Table AbbVie Company Details
        Table AbbVie Revenue in Liver Diseases Therapeutics Drugs Business (2013-2018)(Million US$)
        Figure AbbVie Revenue Growth Rate in Liver Diseases Therapeutics Drugs Business (2013-2018)
        Table AbbVie Recent Development
        Table Angion Biomedica Company Details
        Table Angion Biomedica Revenue in Liver Diseases Therapeutics Drugs Business (2013-2018)(Million US$)
        Figure Angion Biomedica Revenue Growth Rate in Liver Diseases Therapeutics Drugs Business (2013-2018)
        Table Angion Biomedica Recent Development
        Table Bayer Company Details
        Table Bayer Revenue in Liver Diseases Therapeutics Drugs Business (2013-2018)(Million US$)
        Figure Bayer Revenue Growth Rate in Liver Diseases Therapeutics Drugs Business (2013-2018)
        Table Bayer Recent Development
        Table LG Life Sciences Company Details
        Table LG Life Sciences Revenue in Liver Diseases Therapeutics Drugs Business (2013-2018)(Million US$)
        Figure LG Life Sciences Revenue Growth Rate in Liver Diseases Therapeutics Drugs Business (2013-2018)
        Table LG Life Sciences Recent Development
        Table Phenex Pharmaceuticals Company Details
        Table ProMetic Life Sciences Company Details
        Table Raptor Pharmaceuticals Company Details
        Table Shenzhen Kangtai Biological Products Company Details
        Table Verva Pharmaceuticals Company Details
        Table Global Liver Diseases Therapeutics Drugs Market Size by Regions (Million US$) 2018-2025
        Figure Global Liver Diseases Therapeutics Drugs Market Size Share by Regions (2018-2025)
        Figure Global Liver Diseases Therapeutics Drugs Market Size Share by Regions in 2025
        Figure United States Liver Diseases Therapeutics Drugs Market Size Forecast (2018-2025)(Million USD)
        Figure Europe Liver Diseases Therapeutics Drugs Market Size Forecast (2018-2025)(Million USD)
        Figure China Liver Diseases Therapeutics Drugs Market Size Forecast (2018-2025)(Million USD)
        Figure Japan Liver Diseases Therapeutics Drugs Market Size Forecast (2018-2025)(Million USD)
        Figure Southeast Asia Liver Diseases Therapeutics Drugs Market Size Forecast (2018-2025)(Million USD)
        Figure India Liver Diseases Therapeutics Drugs Market Size Forecast (2018-2025)(Million USD)
        Figure Central & South America Liver Diseases Therapeutics Drugs Market Size Forecast (2018-2025)(Million USD)
        Table Global Liver Diseases Therapeutics Drugs Market Size by Product (2018-2025) (Million US$)
        Figure Global Liver Diseases Therapeutics Drugs Market Size by Product (2018-2025)
        Figure Global Liver Diseases Therapeutics Drugs Market Size by Product in 2025
        Table Global Liver Diseases Therapeutics Drugs Market Size by Application (2018-2025) (Million US$)
        Figure Global Liver Diseases Therapeutics Drugs Market Size by Application (2018-2025)
        Figure Global Liver Diseases Therapeutics Drugs Market Size by Application in 2025
        Table Research Programs/Design for This Report
        Figure Bottom-up and Top-down Approaches for This Report
        Figure Data Triangulation
        Table Key Data Information from Secondary Sources
        Table Key Data Information from Primary Sources